Healthcare
Live Price
Offline$94.81
+0.16% today
1Y Change
+51.28%
Window
Jun 26, 2025 → Jun 16, 2026
Coverage: 244 bars · Jun 26, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
IRadimed Corporation (IRMD) is a Healthcare stock with a market cap of $1.09B and listed on NASDAQ. The stock last traded around $94.81 and up 51.3% across the available one-year price window (Jun 26, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +14.4%, EPS growth of +16.4%, a dividend yield of 1.4%. What stands out right now is revenue +14.4%, EPS +16.4%, free cash flow -2.5% with operating margin 32.4% and ROIC 21.4%. The dividend is present but secondary, with a yield around 1.4%. Valuation already assumes a fairly strong business story at P/E 46.0 and price/sales 12.6. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines IRMD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
IRMD
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
IRMD Max Drawdown
-20.65%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for IRMD and SPY.
Unable to load analyst forecasts.
Timed out loading forecasts for IRMD
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.